| Teva Pharma AG - Sunitinib-Teva 50 mg, Hartkapseln | | 67781 | | 04 | | Sunitinib-Teva 50 mg | | Hartkapseln | | L01EX01 | | | | 15.02.2021 | | |
| | Composition | | sunitinibum 50 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.31 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Sunitinib | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Sunitinib | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | | | | Mannitol | | | | | 25 | | | | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 28 | 3046.34 | 3329.50 | A | SL | No |
|
|
